IP Verse

Artificial Nucleic Acid Molecules For Improved Protein Expression - EP4023755

The patent EP4023755 was granted to Curevac on Apr 26, 2023. The application was originally filed on Dec 11, 2015 under application number EP21209125A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4023755

CUREVAC
Application Number
EP21209125A
Filing Date
Dec 11, 2015
Status
Granted And Under Opposition
Mar 24, 2023
Grant Date
Apr 26, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

COOLEY UKJan 26, 2024ADMISSIBLE
PFIZERJan 26, 2024ADMISSIBLE
SANOFIJan 26, 2024ADMISSIBLE
BIONTECHDec 6, 2023ADMISSIBLE

Patent Citations (55) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2013EP03946-
DESCRIPTIONWO2014EP03334-
DESCRIPTIONUS4373071
DESCRIPTIONUS4401796
DESCRIPTIONUS4415732
DESCRIPTIONUS4458066
DESCRIPTIONUS4500707
DESCRIPTIONUS4668777
DESCRIPTIONUS4973679
DESCRIPTIONUS5047524
DESCRIPTIONUS5132418
DESCRIPTIONUS5153319
DESCRIPTIONUS5262530
DESCRIPTIONUS5700642
DESCRIPTIONWO02098443
DESCRIPTIONWO2010037539
DESCRIPTIONWO2012019780
DESCRIPTIONWO2013143700
OPPOSITIONEP2762165
OPPOSITIONEP3167059
OPPOSITIONEP3594337
OPPOSITIONEP3708668
OPPOSITIONEP4023755
OPPOSITIONUS2004110295
OPPOSITIONUS2009093433
OPPOSITIONWO0107590
OPPOSITIONWO02098443
OPPOSITIONWO2005075644
OPPOSITIONWO2007036366
OPPOSITIONWO2007068265
OPPOSITIONWO2008112127
OPPOSITIONWO2010037539
OPPOSITIONWO2011005799
OPPOSITIONWO2013090648
OPPOSITIONWO2013120628
OPPOSITIONWO2013120629
OPPOSITIONWO2013143698
OPPOSITIONWO2013143699
OPPOSITIONWO2013143700
OPPOSITIONWO2015101415
OPPOSITIONWO2016005324
OPPOSITIONWO2016011306
OPPOSITIONWO2016091391
OPPOSITIONWO9914346
SEARCHWO0107590
SEARCHWO02098443
SEARCHWO2005075644
SEARCHWO2007036366
SEARCHWO2007068265
SEARCHWO2008112127
SEARCHWO2013120629
SEARCHWO2013143698
SEARCHWO2013143699
SEARCHWO2013143700
SEARCHWO2015101415

Non-Patent Literature (NPL) Citations (63) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- AKASHI, Curr. Opin. Genet. Dev., (20010000), vol. 11, no. 6, pages 660 - 666-
DESCRIPTION- CLIQUET F.AUBERT M.SAGNE L., J. Immunol. Methods, (19980000), vol. 212, pages 79 - 87-
DESCRIPTION- DAVILA LOPEZ, M.SAMUELSSON, T., RNA (New York, N.Y., (20080000), vol. 14, no. 1, pages 1 - 10-
DESCRIPTION- DOMINSKI, Z.W. F. MARZLUFF, Gene, (20070000), vol. 396, no. 2, pages 373 - 90-
DESCRIPTION- FRIEDEL et al., "Conserved principles of mammalian transcriptional regulation revealed by RNA half-life", Nucleic Acid Research, (20090000), vol. 1-12-
DESCRIPTION- MEYUHAS et al., Translational Control of Ribosomal Protein mRNAs in Eukaryotes, Translational Control, Cold Spring Harbor Laboratory Press, (19960000), pages 363 - 388-
DESCRIPTION- PANDEY, N. B. et al., Nucleic Acids Research, (19900000), vol. 18, no. 11, pages 3161 - 3170-
DESCRIPTION- PANDEY, N. B. et al., "Vertebrate mRNAs with a 5'-terminal pyrimidine tract are Candidates for translational repression in quiescent cells: characterization of the translational cis-regulatory element", Molecular and Cellular Biology, (19940000), vol. 14, no. 3, pages 3822 - 3833-
DESCRIPTION- PANDEY, N. B.MARZLUFF, W. F., Molecular and Cellular Biology, (19870000), vol. 7, no. 12, pages 4557 - 4559-
DESCRIPTION- RODGERS et al., "Regulated a-globin mRNA decay is a cytoplasmic event proceeding through 3'-to-5' exosome-dependent decapping", RNA, (20020000), vol. 8, pages 1526 - 1537-
DESCRIPTION- SANCHEZ, R.W. F. MARZLUFF, Mol Cell Biol, (20040000), vol. 24, no. 6, pages 2513 - 25-
DESCRIPTION- WANG et al., "An mRNA stability complex functions with poly(A)-binding protein to stabilize mRNA in vitro", Molecular and Cellular Biology, (19990700), vol. 19, no. 7, pages 4552 - 4560-
DESCRIPTION- WHITELAW, E. et al., Nucleic Acids Research, (19860000), vol. 14, no. 17, pages 7059 - 7070-
DESCRIPTION- WILLIAMS, A. S.MARZLUFF, W. F., Nucleic Acids Research, (19950000), vol. 23, no. 4, pages 654 - 662-
DESCRIPTION- JOHNSON et al., "Newly synthesized RNA: Simultaneous measurement in intact cells of transcription rates and RNA stability of insulin-like growth factor I, actin, and albumin in growth hormone-stimulated hepatocytes", Proc. Natl. Acad. Sci., (19910000), vol. 88, doi:10.1073/pnas.88.12.5287, pages 5287 - 5291, XP002332485
DESCRIPTION- ZHAO et al., "Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor", Caner Res., (20100000), vol. 70, no. 22, doi:10.1158/0008-5472.CAN-10-2880, pages 9053 - 9061, XP055072178
DESCRIPTION- HOLTKAMP et al., "Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells", Blood, (20060000), vol. 108, doi:10.1182/blood-2006-04-015024, pages 4009 - 4017, XP055044965
DESCRIPTION- LADEVAIA et al., "All translation elongation factors and the e, f, and h subunits of translation initiation factor 3 are encoded by 5'-terminal oligopyrimidine (TOP) mRNAs", RNA, (20080000), vol. 14, doi:10.1261/rna.1037108, pages 1730 - 1736, XP055044697
OPPOSITION- Anonymous, "in vivo-jetPEI® in vivo transfection reagent - Polyplus®", Polyplus-sartorius, (20240528), pages 1 - 17, Polyplus-sartorius, URL: https://www.polyplus-sartorius.com/products/in-vivo-jetpei#product_datas-9, XP093170082-
OPPOSITION- Anonymous, "Ovalbumin", Wikipedia, (20230629), pages 1 - 3, Wikipedia , URL: https://en.wikipedia.org/w/index.php?title=Ovalbumin&oldid=1162529069, (20240703), XP093181626-
OPPOSITION- D100 - Further declaration by from the University of Salzburg, Hellbrunnerstrasse 34, 5020 Salzburg, Austria-
OPPOSITION- D102 - Document D63 from the parallel opposition proceedings concerning EP 3 708 668 B1-
OPPOSITION- D87: Judgment of the UK Court [2024] EWHC 2538 (Pat), handed down October 8, 2024-
OPPOSITION- D88a: GERMAN ORIGINAL OF AN INTERNAL COMMUNICATION AT CUREVAC CONCERNING THE EXAMINATION PROCEEDINGS-
OPPOSITION- D88b: ENGLISH TRANSLATION OF D84A-
OPPOSITION- D89: EXPERIMENTAL DATA FROM THE UNIVERSITY OF SALZBURG, HELLBRUNNERSTRASSE 34, 5020 SALZBURG, AUSTRIA-
OPPOSITION- D90: PRINTOUT FROM HTTPS://WWW.SCBT.COM/DE/P/LUCIFERASE-ANTIBODY-C-12-
OPPOSITION- D91: SEQUENCE ALIGNMENT BETWEEN SEQ ID NO: 181 AND WILD-TYPE LUCIFERASE-
OPPOSITION- D92: ORDER BY THE COURT OF APPEAL IN THE UK-
OPPOSITION- Herweijer et al., "A Plasmid-Based Self-Amplifying Sindbis Virus Vector ", Human Gene Therapy , (1995), vol. 6, XP000789885-
OPPOSITION- Hugo A Barrera-Saldaña, Genetic Engineering - Basics, New Applications and Responsibilities, (20110101), pages 11 - 12, XP093159817-
OPPOSITION- P.L. FELGNER, Y. BARENHOLZ, J.P. BEHR, S.H. CHENG, P. CULLIS, L. HUANG, J.A. JESSEE, L. SEYMOUR, F. SZOKA, A.R. THIERRY, E. WAGNER,G. W U, "Nomenclature for Synthetic Gene Delivery Systems", HUMAN GENE THERAPY, (19970320), vol. 8, pages 511 - 512, XP093159220-
OPPOSITION- "RecName: Full=Mucin-1", UniProtKB, (20141126), Database accession no. P15941 , XP093159813-
OPPOSITION- Riley Rachel S, Et Al, "Ionizable lipid nanoparticles for in utero mRNA delivery", Sci. Adv, (20210113), pages 1 - 15, Sci. Adv, URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7806221/pdf/aba1028.pdf, XP093170147-
OPPOSITION- Sachs null, "The role of poly(A) in the translation and stability of mRNA ", Current Opinion in Cell Biology , (1990), vol. 2, doi:10.1016/0955-0674(90)90161-7, XP025481525
OPPOSITION- Mockey, M. ; Goncalves, C. ; Dupuy, F.P. ; Lemoine, F.M. ; Pichon, C. ; Midoux, P., "mRNA transfection of dendritic cells: Synergistic effect of ARCA mRNA capping with Poly(A) chains in cis and in trans for a high protein expression level", Biochemical and Biophysical Research Communications, Elsevier, Amsterdam NL, Amsterdam NL , (20060224), vol. 340, no. 4, doi:10.1016/j.bbrc.2005.12.105, ISSN 0006-291X, pages 1062 - 1068, XP024924154
OPPOSITION- Ledda, M. Di Croce, M. Bedini, B. Wannenes, F. Corvaro, M. Boyl, P.P. Caldarola, S. Loreni, F. Amaldi, F., "Effect of 3'UTR length on the translational regulation of 5'-terminal oligopyrimidine mRNAs", Gene, Elsevier Amsterdam, NL, NL , (20050103), vol. 344, doi:10.1016/j.gene.2004.09.023, ISSN 0378-1119, pages 213 - 220, XP004712180
OPPOSITION- Nishat Sultana et al, "Optimizing Cardiac Delivery of Modified mRNA", Molecular Therapy, Elsevier Inc., US, US , (20170601), vol. 25, no. 6, doi:10.1016/j.ymthe.2017.03.016, ISSN 1525-0016, pages 1306 - 1315, XP055649234
OPPOSITION- "Oversized AAV Transductifon Is Mediated via a DNA-PKcs-independent, Rad51C-dependent Repair Pathwa", MOLECULAR THERAPY, (20131201), vol. 21, no. 12, doi:10.1038/mt.2013.184, pages 2205 - 2216, XP002797872
OPPOSITION- Sahin et al., "mRNA-based therapeutics - developing a new class of drugs ", Nature Reviews | Drug Discovery, (2014), vol. 13, doi:10.1038/nrd4278, XP055544673
OPPOSITION- Sahin Ugur; Karikó Katalin; Türeci Özlem, "mRNA-based therapeutics — developing a new class of drugs", Nature Reviews Drug Discovery, Nature Publishing Group, GB, GB , (20140919), vol. 13, no. 10, doi:10.1038/nrd4278, ISSN 1474-1776, pages 759 - 780, XP037134862
OPPOSITION- POLO JOHN M ET AL, "Stable alphavirus packaging cell lines for Sindbis virus-and Semliki Forest virus-derived vectors.", Proceedings of the National Academy of Sciences, National Academy of Sciences, (19990413), vol. 96, no. 8, doi:10.1073/pnas.96.8.4598, ISSN 0027-8424, pages 4598 - 4603, XP002139370
OPPOSITION- DiCiommo et al., "Rapid, High Level Protein Production Using DNA-based Semliki Forest Virus Vectors", The Journal of Biological Chemistry, (1998), vol. 273, doi:10.1074/jbc.273.29.18060, XP055275933
OPPOSITION- Borman Andrew M., Michel Yanne M., Malnou Cécile E., Kean Katherine M., "Free Poly(A) Stimulates Capped mRNA Translation in Vitro through the eIF4G-Poly(A)-binding Protein Interaction", Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, US, US , (20020927), vol. 277, no. 39, doi:10.1074/jbc.M205065200, ISSN 0021-9258, pages 36818 - 36824, XP093088399
OPPOSITION- Mccarthy Sean D, Rohde Christopher B.; Angel Matt; Masterson Claire H.; Macloughlin Ronan; Fandiño Juan; González Héctor E.; Byrnes Declan; Laffey John G.; O'toole Daniel, "Aerosolized Pulmonary Delivery of mRNA Constructs Attenuates Severity of Escherichia coli Pneumonia in the Rat", Nucleic Acid Therapeutics, Mary Ann Liebert, Inc. Publishers, US, US , (20230401), vol. 33, no. 2, doi:10.1089/nat.2022.0049, ISSN 2159-3337, pages 148 - 158, XP093170099
OPPOSITION- YONAHA M, PROUDFOOT N J, "Transcriptional termination and coupled polyadenylation in vitro", The EMBO journal / European Molecular Biology Organization, IRL Press, Oxford, Oxford , (20000101), vol. 19, no. 14, doi:10.1093/emboj/19.14.3770, ISSN 0261-4189, pages 3770 - 3777, XP002974886
OPPOSITION- James H. Mccutchan, "Enhancement of the Infectivity of Simian Virus 40 Deoxyribonucleic Acid With Dlethyl- aminoethyl-Dextran ", JNCI: Journal of the National Cancer Institute, (19680801), vol. 41, no. 2, doi:10.1093/jnci/41.2.351, pages 351 - 357, XP093159219
OPPOSITION- Gallie D.R., Lewis N.J., Marzluff W.F., "The histone 3'-terminal stem-loop is necessary for translation in Chinese hamster ovary cells", Nucleic Acids Research, Oxford University Press, GB, GB , (19960515), vol. 24, no. 10, doi:10.1093/nar/24.10.1954, ISSN 0305-1048, pages 1954 - 1962, XP002616165
OPPOSITION- Ferrari M. E., Rusalov Denis, Enas Joel, Wheeler Carl J, "Trends in lipoplex physical properties dependent on cationic lipid structure, vehicle and complexation procedure do not correlate with biological activity", Nucleic Acids research, Oxford University Press, GB, GB , (20010401), vol. 29, no. 7, doi:10.1093/nar/29.7.1539, ISSN 1362-4962, pages 1539 - 1548, XP093148217
OPPOSITION- T W Dubensky, "Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer", Journal of Virology, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, US , (19960101), vol. 70, no. 1, doi:10.1128/jvi.70.1.508-519.1996, ISSN 0022-538X, pages 508 - 519, XP093159267
OPPOSITION- Zuckerman, "The importance of injecting vaccines into muscle.", BMJ, (20001128), vol. 321, doi:10.1136/bmj.321.7271.1237, pages 1237 - 1238, XP055747296
OPPOSITION- S. Holtkamp, S. Kreiter, A. Selmi, P. Simon, M. Koslowski, C. Huber, O. Tureci, U. Sahin, "Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells", Blood, (20061215), vol. 108, no. 13, doi:10.1182/blood-2006-04-015024, ISSN 00064971, pages 4009 - 4017, XP055044965
OPPOSITION- Trepotec Zeljka; Geiger Johannes; Plank Christian; Aneja Manish K; Rudolph Carsten, "Segmented poly(A) tails significantly reduce recombination of plasmid DNA without affecting mRNA translation efficiency or half-life", RNA, COLD SPRING HARBOR LABORATORY PRESS, US, US , (20190331), vol. 25, no. 4, doi:10.1261/rna.069286.118, ISSN 1355-8382, pages 507 - 518, XP009517039
OPPOSITION- Iadevaia et al., "All translation elongation factors and the e, f, and h subunits of translation initiation factor 3 are encoded by 59-terminal oligopyrimidine (TOP) mRNAs", RNA , (2008), vol. 14, doi:10.1261/rna.1037108, XP055044697
OPPOSITION- Milone et al., "Characterization of deadenylation in trypanosome extracts and its inhibition by poly(A)-binding protein Pab1p ", RNA, (2004), vol. 10, doi:10.1261/rna.5180304, XP093088409
OPPOSITION- Milone Joseph, Wilusz Jeffrey, Bellofatto Vivian, "Characterization of deadenylation in trypanosome extracts and its inhibition by poly(A)-binding protein Pab1p", RNA, COLD SPRING HARBOR LABORATORY PRESS, US, US , (20040101), vol. 10, doi:10.1261/rna.5180304, ISSN 1355-8382, pages 448 - 457, XP093088409
OPPOSITION- Firdessa-Fite Rebuma, Postigo-Fernandez Jorge, Toussaint-Moreau Valérie, Stock Fabrice, Nyamay’antu Alengo, Erbacher Patrick, Creusot Rémi J, "Promising non-viral vector for efficient and versatile delivery of mRNA for antigen-specific immunotherapy", Cell and Gene Therapy Insights, (20201029), vol. 6, no. 9, doi:10.18609/cgti.2020.154, ISSN 2059-7800, pages 1399 - 1409, XP093020997
OPPOSITION- Andreani Julien, Khalil Jacques Y. B., Baptiste Emeline, Hasni Issam, Michelle Caroline, Raoult Didier, Levasseur Anthony, La Scola Bernard, "Orpheovirus IHUMI-LCC2: A New Virus among the Giant Viruses", Frontiers in Microbiology, Frontiers Media, Lausanne, Lausanne , vol. 8, doi:10.3389/fmicb.2017.02643, ISSN 1664-302X, XP093148218
OPPOSITION- Thomas Schlake, Andreas Thess, Mariola Fotin-Mleczek, Karl-Josef Kallen, "Developing mRNA-vaccine technologies", RNA BIOLOGY, (20121101), vol. 9, no. 11, doi:10.4161/rna.22269, ISSN 1547-6286, pages 1319 - 1330, XP055561756
OPPOSITION- Khanam Tasneem, Muddashetty Ravi Sondekoppa, Kahvejian Avak, Sonenberg Nahum, Brosius Juergen, "Poly(A)-Binding Protein Binds to A-Rich Sequences via RNA-Binding Domains 1+2 and 3+4", RNA BIOLOGY, (20060101), vol. 3, no. 4, doi:10.4161/rna.3.4.4075, ISSN 1547-6286, pages 170 - 177, XP093088415
SEARCH- "Homo sapiens RPL36AL mRNA for ribosomal protein L36a-like, complete cds", EMBL, (20021002), XP002699423 [A] 1-27 * abstract *-
SEARCH- LEDDA M ET AL, "Effect of 3'UTR length on the translational regulation of 5'-terminal oligopyrimidine mRNAs", GENE, ELSEVIER, AMSTERDAM, NL, vol. 344, ISSN 0378-1119, (20050103), pages 213 - 220, (20050103), XP027872598 [A] 1-27 * the whole document *-
SEARCH- S. HOLTKAMP ET AL, "Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells", BLOOD, (20061215), vol. 108, no. 13, doi:10.1182/blood-2006-04-015024, ISSN 0006-4971, pages 4009 - 4017, XP055044965 [A] 1-27 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents